Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: Publication

PoxSTG-EEV: a Novel Enveloped Virion – Based Formulation of a Chimeric Oncolytic PoxVirus Adapted for Systemic Delivery

J. Foloppe et al. SITC 2026 – Abstract available on the SITC website – Download the Abstract– Download the Poster

Published 3 November 2026
Categorized as -others, 2026, 2026, Publication, publication key en

Synthetic genome shuffling of poxviruses in yeast generates novel poxvirus candidates with potential oncolytic properties

A. Agaoua et al. frontiers in Bioengineering and Biotechnology – Article available on the frontiers website – Download the Article

Published 15 October 2026
Categorized as -others, 2026, 2026, Publication, publication key en

A viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: a randomized Phase I trial

C. Ottensmeier, et al. Article available on Nature Communications website – Download the Article

Published 2 September 2026
Categorized as 2026, Myvac, Publication, publication key en, TG4050

Therapeutic Poxviruses Induce the Secretion of Immunostimulating and Anti-Tumoral Extracellular Vesicles

L. Walther, et al. Article available on ISEV website – Download the Article

Published 19 June 2026
Categorized as -others, 2026, Publication

Robust Protection Against Monkeypox Virus Mediated by a Novel Cell‑Line–Derived MVA Vaccine (TG-MVACL)

N. Silvestre, et al. World Congress on Infectious Diseases WCID 2026 Abstract available on WCID website – Download the abstract – Download the oral presentation

Published 26 May 2026
Categorized as -others, 2026, 2026, Publication

Synthetic Genome Shuffling of Poxviruses via Yeast TAR Cloning for Next-Generation Oncolytic Platforms

A. Agaoua et al. International Oncolytic Virus Conference 2026 – Download the Abstract – Download the Poster

Published 26 April 2026
Categorized as -others, 2026, 2026, Publication, publication key en

TG4050, an Individualized Neoantigen Therapeutic Vaccine in Early-Stage Cancer Treatment

K. Bidet-Huang World Vaccine Congress 2026 – Download the Oral Presentation

Published 1 April 2026
Categorized as 2026, Myvac, Publication, publication key en, TG4050

Viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trial

C. Ottensmeier, et al. medRxiv Preprint available on medRxiv website – Download the Article

Published 9 January 2026
Categorized as 2026, Myvac, Publication, publication key en, TG4050

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery

P. Erbs, et al. Cancers 2025 Abstract available on the MDPI website – Download the article

Published 19 November 2025
Categorized as -others, 2025, Invir.IO, Publication, TG6002

VacDesignR®: a Tool for Optimizing Recombinant Poxvirus Vaccine Production

B. Grellier, et al. ESMO-AI 2025 Abstract available on ESMO-AI website – Download the abstract – Download the Poster

Published 12 November 2025
Categorized as 2025, Myvac, Publication, publication key en, TG4050

Posts pagination

Page 1 … Page 13 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu